peptide 1 glp 1 receptor agonist GLP-1 agonists show promise in treating substance use disorders A System-Based Review on Effects

What Is GLP-1 and Why Does It Matter

There are actually many more

Introduction Concerns about thyroid cancer with glucagon-like peptide 1 (GLP1) receptor agonist use were first raised in the premarketing phase after studies showed increased rates of thyroid C cell tumours in rodents.1 While the relevance of these findings to humans is not known, in the United States, product labels of GLP1 receptor agonists include boxed warnings about thyroid cancer and these drugs are contraindicated in patients with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia type 2

Diabetes Obes Metab (2013) 15(10):87181

BMC Endocrine Disorders, 23 (245)

And in a year where health care cost trends are running at 8% to 10% and climbing, the advisors are the ones who will grow their books